Post-approval studies (Phase 4)Ended earlyNCT01129557
What this trial is testing
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Who this might be right for
Proteinuric Kidney DiseaseDiabetic NephropathyHypertensive Nephrosclerosis+4 more
Columbia University 46